Palisade bio to present at the virtual investor pitch conference

Live video webcast on monday, june 17 th at 12:00 pm et carlsbad, ca, june 10, 2024 (globe newswire) -- palisade bio, inc. (nasdaq: pali) (“palisade” or the “company”), biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it will present at the virtual investor pitch conference on june 17, 2024 at 12:00 pm et. as part of the event, j.d.
PALI Ratings Summary
PALI Quant Ranking